# A Study of Open Angle Glaucoma or Ocular Hypertension in Patients Within Scandinavia

> **NCT00751062** · PHASE3 · COMPLETED · sponsor: **Pfizer's Upjohn has merged with Mylan to form Viatris Inc.** · enrollment: 267 (actual)

## Conditions studied

- Open Angle Glaucoma
- Ocular Hypertension

## Interventions

- **DRUG:** timolol
- **DRUG:** PhXA41

## Key facts

- **NCT ID:** NCT00751062
- **Lead sponsor:** Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1992-11
- **Primary completion:** 1993-12
- **Final completion:** 1993-12
- **Target enrollment:** 267 (ACTUAL)
- **Last updated:** 2021-02-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00751062

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00751062, "A Study of Open Angle Glaucoma or Ocular Hypertension in Patients Within Scandinavia". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT00751062. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*